BAAM
ASMB icon

Baker Avenue Asset Management’s Assembly Biosciences ASMB Stock Holding History

Baker Avenue Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-83
Closed -$885 – 450
2023
Q3 		$885 Hold
83
– – ﹤0.01% 1313
2023
Q2 		$1.15K Hold
83
– – ﹤0.01% 1134
2023
Q1 		$840 Buy
+83
New +$1.4K ﹤0.01% 1247

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baker Avenue Asset Management's ASMB Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Assembly Biosciences (ASMB) in Q4 2023, closing a stake of 83 shares — an estimated $885 sold.

Baker Avenue Asset Management first reported a position in ASMB in Q1 2023 and held it in 3 quarters. The position peaked at $1.15K in Q2 2023. 44 funds tracked by Wall St. Rank hold ASMB as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Assembly Biosciences position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 83 Assembly Biosciences shares in Q4 2023, an estimated $885.
  • Baker Avenue Asset Management first reported a position in Assembly Biosciences in Q1 2023 and held it in 3 quarters.
  • Baker Avenue Asset Management's Assembly Biosciences position peaked at $1.15K in Q2 2023.
  • 44 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.